The role of Flightless in the formation of scar formation and potential as a target for a novel therapy to reduce scarring

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1038104

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Scarring causes significant morbidity and suffering. It can lead to pain, disfigurement and impaired physical function, which require costly ongoing care. Flightless (Flii) is a novel protein, which acts as a negative regulator of wound healing. Flii neutralising antibody treatment has been shown to improve wound healing. However, the role of Flii in scarring has yet to be investigated. This project will investigate the role of Flii in scarring and its potential as a therapeutic target.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2013

Funding Scheme: Postgraduate Scholarships

Funding Amount: $60,664.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

burn injury | fibrosis | scar formation | scarring | skin | surgery | trauma | wound reepithelialisation | wound repair | wounds

Related Links